Management of neurourological patients during the COVID-19 pandemia

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Padilla-Fernandez, B
  • Hernandez-Hernandez, D
  • Blasco-Hernandez, P
  • Carela-Espin, J
  • Errando-Smet, C
  • Cortes, MJGM
  • Garcia-Moreno, AML
  • Lavalle, LLF
  • Madurga-Patue, B
  • Resel-Folkersma, L
  • Sanchez-Merino, JM
  • Zubiaur-Libano, MD
  • Castro-Diaz, DM

Grupos

Abstract

OBJECTIVES: To report the recommendations of an expert panel to reorganize Neurourology units and to prioritize examinations and both conservative and surgical treatments during the COVID-19 pandemic. MATERIALS AND METHODS: Non-systematic review of the literature and national experts' opinion summarizing the recommendations in the diagnosis, management, and follow-up of neurourological patients during the COVID-19 pandemic. A modified nominal group technique was used due to extraordinary meeting and mobility restrictions during COVID-19 pandemic. RESULTS: Neurourological patients have special physiological and pathological characteristics that make them more vulnerable to SARS-CoV-2 infection. For prioritization purposes, they encompass in Functional Urology patients and their management is considered non-urgent or delayable with no specific deadline of recovery from normality. However, it is important to identify individual situations jeopardising the upper urinary tract, urinary retention or predisposing to urinary infections/sepsis. A classification is provided prioritizing conservative/outpatient management and the surgical treatment of the events occurring in neurourological patients during the COVID-19 pandemic. CONCLUSIONS: In neurourological patients we can find exceptional clinical situations in which a delayed treatment could develop irreversible changes in the upper urinary tract, advocating a more urgent treatment in specific scenarios.

Datos de la publicación

ISSN/ISSNe:
0004-0614, 1576-8260

ARCHIVOS ESPANOLES DE UROLOGIA  INIESTARES, S.A.

Tipo:
Article
Páginas:
429-437
DOI:
PubMed:
32538814
Factor de Impacto:
0,310 SCImago
Cuartil:
Q3 SCImago

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • COVID-19; SARS-CoV-2; Neurourology; High-risk bladder

Compartir